相似文献
1
Pulmonary hypertension in hydralazine induced systemic lupus erythematosus: association with C4 null allele.
Ann Rheum Dis. 1986 Sep;45(9):771-3. doi: 10.1136/ard.45.9.771.
2
Complement system protein C4 and susceptibility to hydralazine-induced systemic lupus erythematosus.
Lancet. 1989 Apr 29;1(8644):922-4. doi: 10.1016/s0140-6736(89)92506-3.
3
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility.
Lancet. 1980 May 24;1(8178):1107-9. doi: 10.1016/s0140-6736(80)91554-8.
4
C4 null alleles in childhood onset systemic lupus erythematosus. Is there any relationship with renal disease?
Pediatr Nephrol. 1990 May;4(3):207-12. doi: 10.1007/BF00857655.
5
Null alleles of the fourth component of complement and HLA haplotypes in familial systemic lupus erythematosus.
Immunogenetics. 1985;21(4):299-311. doi: 10.1007/BF00430796.
6
Hydralazine sensitivity: clinical features, autoantibody changes and HLA-DR phenotype.
Q J Med. 1987 Oct;65(246):845-52.
7
The immunogenetics of SLE.
Clin Rheum Dis. 1982 Apr;8(1):3-21.
8
Hydralazine and lupus nephritis.
Clin Nephrol. 1984 Nov;22(5):230-8.
9
Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.
Br Med J (Clin Res Ed). 1983 Feb 5;286(6363):425-8. doi: 10.1136/bmj.286.6363.425.
10
Acetylator phenotype and lupus erythematosus.
Clin Pharmacokinet. 1981 Mar-Apr;6(2):118-34. doi: 10.2165/00003088-198106020-00003.
引用本文的文献
1
Pulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodies.
Ann Rheum Dis. 1989 Mar;48(3):232-5. doi: 10.1136/ard.48.3.232.
本文引用的文献
1
Pulmonary hypertension in rheumatoid arthritis: report of a case with intimal sclerosis of the pulmonary and digital arteries.
Scott Med J. 1957 May;2(5):183-8. doi: 10.1177/003693305700200502.
2
Pulmonary hypertension in dermatomyositis.
Br Heart J. 1956 Apr;18(2):273-6. doi: 10.1136/hrt.18.2.273.
3
Hydrallazine-induced cutaneous vasculitis.
Br Med J. 1980 Jan 19;280(6208):156-7. doi: 10.1136/bmj.280.6208.156-a.
4
The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients.
Am J Med. 1981 Nov;71(5):791-8. doi: 10.1016/0002-9343(81)90366-1.
5
[A case of Sjögren's syndrome with pulmonary hypertension, hypergammaglobulinemia and thrombocytopenia (author's transl)].
Nihon Naika Gakkai Zasshi. 1982 Jan 10;71(1):71-6.
6
Drug-induced lupus: clinical and serological studies.
Clin Rheum Dis. 1982 Apr;8(1):121-35.
7
Hydralazine, antinuclear antibodies, and the lupus syndrome.
Br Med J (Clin Res Ed). 1982 Mar 27;284(6320):936-9. doi: 10.1136/bmj.284.6320.936.
8
Systemic lupus erythematosus and pulmonary vascular hypertension.
Arch Intern Med. 1984 Mar;144(3):605-7.
9
Fatal post-partum pulmonary vasculitis in systemic lupus erythematosus.
Clin Rheumatol. 1984 Dec;3(4):547-50. doi: 10.1007/BF02031281.
10
The lupus anticoagulant, pulmonary thromboembolism, and fatal pulmonary hypertension.
Ann Rheum Dis. 1984 Oct;43(5):760-3. doi: 10.1136/ard.43.5.760.
Zotero 插件